These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12576180)

  • 1. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining.
    Ballok DA; Millward JM; Sakic B
    Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal damage in mouse and human forms of systemic autoimmune disease.
    Ballok DA; Woulfe J; Sur M; Cyr M; Sakic B
    Hippocampus; 2004; 14(5):649-61. PubMed ID: 15301441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased TUNEL staining in brains of autoimmune Fas-deficient mice.
    Sakic B; Maric I; Koeberle PD; Millward JM; Szechtman H; Maric D; Denburg JA
    J Neuroimmunol; 2000 May; 104(2):147-54. PubMed ID: 10713354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice.
    Ballok DA; Earls AM; Krasnik C; Hoffman SA; Sakic B
    J Neuroimmunol; 2004 Jul; 152(1-2):83-97. PubMed ID: 15223241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.
    Anderson KK; Ballok DA; Prasad N; Szechtman H; Sakic B
    Behav Brain Res; 2006 Jan; 166(1):32-8. PubMed ID: 16183144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice.
    Ma X; Foster J; Sakic B
    J Neuroimmunol; 2006 Oct; 179(1-2):26-36. PubMed ID: 16904195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin.
    James WG; Hutchinson P; Bullard DC; Hickey MJ
    Clin Exp Immunol; 2006 May; 144(2):299-308. PubMed ID: 16634804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
    Drappa J; Brot N; Elkon KB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
    Ashman RF; Singh N; Lenert PS
    Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings.
    Vogelweid CM; Johnson GC; Besch-Williford CL; Basler J; Walker SE
    J Neuroimmunol; 1991 Dec; 35(1-3):89-99. PubMed ID: 1955574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related differences in autoimmune-induced lung lesions in MRL/MpJ-fas
    Elewa YHA; Ichii O; Kon Y
    Autoimmunity; 2017 Aug; 50(5):306-316. PubMed ID: 28665157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
    Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
    J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
    J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
    Mandik-Nayak L; Seo SJ; Sokol C; Potts KM; Bui A; Erikson J
    J Exp Med; 1999 Jun; 189(11):1799-814. PubMed ID: 10359584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L; Takeda K; Akkoyunlu M
    Front Immunol; 2020; 11():1569. PubMed ID: 32849532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central and multiple roles of B cells in lupus pathogenesis.
    Chan OT; Madaio MP; Shlomchik MJ
    Immunol Rev; 1999 Jun; 169():107-21. PubMed ID: 10450512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.